First Allied Advisory Services’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-17,679
| Closed | -$862K | – | 1202 |
|
|
2018
Q3 | $862K | Buy |
+17,679
| New | +$862K | 0.03% | 515 |
|
|
2016
Q4 | – | Sell |
-13,200
| Closed | -$583K | – | 1174 |
|
|
2016
Q3 | $583K | Sell |
13,200
-515
| -4% | -$22.7K | 0.03% | 518 |
|
|
2016
Q2 | $570K | Sell |
13,715
-354
| -3% | -$14.7K | 0.03% | 505 |
|
|
2016
Q1 | $564K | Hold |
14,069
| – | – | 0.03% | 511 |
|
|
2015
Q4 | $715K | Sell |
14,069
-6,275
| -31% | -$319K | 0.04% | 460 |
|
|
2015
Q3 | $958K | Buy |
20,344
+590
| +3% | +$27.8K | 0.05% | 359 |
|
|
2015
Q2 | $1.22M | Buy |
19,754
+938
| +5% | +$58K | 0.05% | 349 |
|
|
2015
Q1 | $1.16M | Buy |
18,816
+12,506
| +198% | +$770K | 0.08% | 308 |
|
|
2014
Q4 | $342K | Sell |
6,310
-11,388
| -64% | -$617K | 0.02% | 685 |
|
|
2014
Q3 | $938K | Buy |
17,698
+566
| +3% | +$30K | 0.07% | 308 |
|
|
2014
Q2 | $887K | Buy |
17,132
+3,330
| +24% | +$172K | 0.07% | 352 |
|
|
2014
Q1 | $644K | Buy |
13,802
+7,364
| +114% | +$344K | 0.05% | 436 |
|
|
2013
Q4 | $282K | Buy |
+6,438
| New | +$282K | 0.02% | 684 |
|